These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2203306)

  • 21. Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime.
    Wong-Beringer A; Hindler J; Loeloff M; Queenan AM; Lee N; Pegues DA; Quinn JP; Bush K
    Clin Infect Dis; 2002 Jan; 34(2):135-46. PubMed ID: 11740699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmid-mediated beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime.
    Vuye A; Verschraegen G; Claeys G
    Antimicrob Agents Chemother; 1989 May; 33(5):757-61. PubMed ID: 2665644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase.
    French GL; Shannon KP; Simmons N
    J Clin Microbiol; 1996 Feb; 34(2):358-63. PubMed ID: 8789016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of a novel plasmid-mediated beta-lactamase, CAZ-2, and the CTX-1 and CAZ-1 enzymes conferring resistance to broad-spectrum cephalosporins.
    Chanal CM; Sirot DL; Labia R; Petit A; Morand A; Sirot JL; Cluzel RA
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1660-5. PubMed ID: 3075436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spread of Klebsiella pneumoniae producing SHV-5 beta-lactamase among hospitalized patients.
    Bauernfeind A; Rosenthal E; Eberlein E; Holley M; Schweighart S
    Infection; 1993; 21(1):18-22. PubMed ID: 8449575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.
    Quinn JP; Miyashiro D; Sahm D; Flamm R; Bush K
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1451-6. PubMed ID: 2684007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes.
    Siu LK; Lu PL; Hsueh PR; Lin FM; Chang SC; Luh KT; Ho M; Lee CY
    J Clin Microbiol; 1999 Dec; 37(12):4020-7. PubMed ID: 10565924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First case of ceftazidime/avibactam administration in home care. ESBL producing Klebsiella pneumoniae bacteremia.
    Torres-Del-Pliego E; Delgado-Mejía E; Gil-Alonso L; Del Mar-Periáñez-Párraga L
    Enferm Infecc Microbiol Clin; 2017 May; 35(5):322-323. PubMed ID: 27712848
    [No Abstract]   [Full Text] [Related]  

  • 29. Trends in Susceptibility Rates and Extended-Spectrum β-Lactamase Production of Klebsiella pneumoniae in Bloodstream Infections Across the United States Veterans Affairs Healthcare System.
    Gentry CA; Williams RJ
    Microb Drug Resist; 2015 Dec; 21(6):590-9. PubMed ID: 26207392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.
    Bradford PA; Urban C; Mariano N; Projan SJ; Rahal JJ; Bush K
    Antimicrob Agents Chemother; 1997 Mar; 41(3):563-9. PubMed ID: 9055993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bactericidal effect of beta-lactams and amikacin alone or in association against Klebsiella pneumoniae producing extended spectrum beta-lactamase.
    Roussel-Delvallez M; Sirot D; Berrouane Y; Goffart M; Gourde B; Wallet F; Courcol RJ
    J Antimicrob Chemother; 1995 Jul; 36(1):241-6. PubMed ID: 8537274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation.
    Schiappa DA; Hayden MK; Matushek MG; Hashemi FN; Sullivan J; Smith KY; Miyashiro D; Quinn JP; Weinstein RA; Trenholme GM
    J Infect Dis; 1996 Sep; 174(3):529-36. PubMed ID: 8769610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins.
    Petit A; Sirot DL; Chanal CM; Sirot JL; Labia R; Gerbaud G; Cluzel RA
    Antimicrob Agents Chemother; 1988 May; 32(5):626-30. PubMed ID: 3293523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of a transferable SHV-5 type beta-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece.
    Vatopoulos AC; Philippon A; Tzouvelekis LS; Komninou Z; Legakis NJ
    J Antimicrob Chemother; 1990 Nov; 26(5):635-48. PubMed ID: 2079446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel, plasmid-encoded, TEM-derived extended-spectrum beta-lactamase in Klebsiella pneumoniae conferring higher resistance to aztreonam than to extended-spectrum cephalosporins.
    Arlet G; Rouveau M; Fournier G; Lagrange PH; Philippon A
    Antimicrob Agents Chemother; 1993 Sep; 37(9):2020-3. PubMed ID: 8239625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia.
    Shields RK; Nguyen MH; Chen L; Press EG; Potoski BA; Marini RV; Doi Y; Kreiswirth BN; Clancy CJ
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. mcr-1 Colistin Resistance in ESBL-Producing Klebsiella pneumoniae, France.
    Caspar Y; Maillet M; Pavese P; Francony G; Brion JP; Mallaret MR; Bonnet R; Robin F; Beyrouthy R; Maurin M
    Emerg Infect Dis; 2017 May; 23(5):874-876. PubMed ID: 28418313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemic and endemic spread of Klebsiella pneumoniae producing SHV-5 beta-lactamase in Dubrava University Hospital, Zagreb, Croatia.
    Bedenić B; Schmidt H; Herold S; Monaco M; Plecko V; Kalenić S; Katíc S; Skrlin-Subić J
    J Chemother; 2005 Aug; 17(4):367-75. PubMed ID: 16167514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outbreak of ceftazidime-resistant Klebsiella pneumoniae in a pediatric hospital in Warsaw, Poland: clonal spread of the TEM-47 extended-spectrum beta-lactamase (ESBL)-producing strain and transfer of a plasmid carrying the SHV-5-like ESBL-encoding gene.
    Gniadkowski M; Palucha A; Grzesiowski P; Hryniewicz W
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3079-85. PubMed ID: 9835494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular basis of extended-spectrum beta-lactamase production in nosocomial isolates of Klebsiella pneumoniae from Mérida, Venezuela.
    Araque M; Nieves B; Lauretti L; Rossolini GM
    Int J Antimicrob Agents; 2000 Jun; 15(1):37-42. PubMed ID: 10856675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.